Evidence suggests that GC1 plays a key role in mutant KRAS-driven metabolic reprogramming of cancer cells through multiple mechanisms, including enhanced glutaminolysis, maintenance of redox homeostasis, and epigenetic regulation of genes involved in cell growth, proliferation, and stemness. This evidence concerns the gene SOD2 and cancer.